Stay updated on Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- Added Revision: v3.4.2 and removed the temporary government funding lapse notice.SummaryDifference0.5%

- Check22 days agoChange DetectedAdded a government funding/NIH operating status notice and updated the site to revision 3.4.1 (replacing 3.4.0).SummaryDifference0.5%

- Check29 days agoChange DetectedAdded a glossary toggle and updated page metadata, including a new 'Last Update Submitted that Met QC Criteria' label and revision note to v3.4.0. The older 'Last Update Submitted that met QC Criteria' label, the 'No FEAR Act data' entry, and the old 'Revision: v3.3.4' were removed.SummaryDifference0.3%

- Check43 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a site revision note: Revision: v3.3.3. Removed the HHS Vulnerability Disclosure and the previous revision note Revision: v3.3.2.SummaryDifference0.1%

- Check86 days agoChange DetectedAdded 'Revision: v3.3.2' and removed 'Revision: v3.3.1' in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1+Radiation in Metastatic Breast Cancer Clinical Trial page.